Calcium D-Glucarate vs NMN (Nicotinamide Mononucleotide)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

Calcium D-GlucarateNMN (Nicotinamide Mononucleotide)
CategorySupplementsSupplements
Standard Dose500-1500mg daily500-1000mg daily
TimingWith meals, split 2-3x/day for sustained beta-glucuronidase inhibition.Morning on empty stomach. Sublingual absorption bypasses first-pass metabolism.
Cycle Durationongoing or cycle with DIM protocolongoing
Evidence Levelmoderate_humanmoderate_human

Mechanism

Calcium D-glucarate is the calcium salt of D-glucaric acid, which is metabolized to D-glucaro-1,4-lactone (the active metabolite). This lactone inhibits beta-glucuronidase, the bacterial enzyme in the gut that deconjugates (cleaves) glucuronide conjugates from Phase II detoxification. By inhibiting beta-glucuronidase, calcium D-glucarate prevents the reabsorption (enterohepatic recirculation) of estrogen, environmental toxins, and carcinogens that were already conjugated for excretion. This effectively enhances the elimination of glucuronidated compounds, including estrogen metabolites, bilirubin, and xenobiotics.

Standard Dosing

500-1500mg daily

Timing

With meals, split 2-3x/day for sustained beta-glucuronidase inhibition.

Cycle Duration

ongoing or cycle with DIM protocol

Side Effects

  • GI discomfort
  • Loose stools
  • Generally very well tolerated

Contraindications

  • Pregnancy/lactation (estrogen clearance effects)
  • Concurrent medications with narrow therapeutic index that undergo glucuronidation

Best Stacking Partners

DIMSulforaphaneNACProbiotics (to modulate gut beta-glucuronidase-producing bacteria)

Mechanism

NMN is a direct biosynthetic precursor to NAD+ via the salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT). Elevated NAD+ activates sirtuins (SIRT1-7), PARP DNA repair enzymes, and CD38/CD157 signaling. SIRT1 activation deacetylates PGC-1alpha (mitochondrial biogenesis), FOXO transcription factors (stress resistance), and NF-kB (anti-inflammatory). NMN also enters cells via the Slc12a8 transporter, recently identified in the gut.

Standard Dosing

500-1000mg daily

Timing

Morning on empty stomach. Sublingual absorption bypasses first-pass metabolism.

Cycle Duration

ongoing

Side Effects

  • Mild GI discomfort
  • Flushing (rare, unlike niacin)
  • Mild headache during initial use

Contraindications

  • Active cancer (theoretical concern: NAD+ may fuel rapidly dividing cells)
  • Pregnancy/lactation (insufficient data)
  • Theoretical concern in active cancer (NAD+ fuels all rapidly dividing cells)

Best Stacking Partners

ResveratrolTMG (Betaine)Vitamin D3Quercetin

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →